Legal status in the United States

Is Sermorelin legal?

Read at FDA, DEA and WADAPublished by PepVault

Sermorelin was FDA-approved as Geref in 1990, and Drugs@FDA now lists it as discontinued, is not a federally controlled substance, and is banned in sport (WADA names it under S2.2.4), as of November 18, 2026.

Sermorelin at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved 1990; discontinued (Drugs@FDA)
CompoundingComponent of an approved drug (503A condition)
DEA scheduleNot controlled
Sport (WADA)Banned, named (S2.2.4)

FDA approval

Sermorelin was FDA-approved as Geref, in 1990 and 1997, and is no longer sold: its maker discontinued both products in 2008, and FDA determined in 2013 that they were not withdrawn for reasons of safety or effectiveness.

The source: “were not withdrawn for reasons of safety or effectiveness”

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Sermorelin is the active ingredient of an FDA-approved drug, Geref, discontinued by its maker in 2008; FDA determined in 2013 that Geref was not withdrawn for reasons of safety or effectiveness. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name sermorelin.

The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA bans sermorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.

The source: “growth hormone-releasing hormone (GHRH) and its analogues (e.g. CJC-1293, CJC-1295, sermorelin and tesamorelin)”

What this means and doesn’t

This page reports what the agencies’ own pages said about Sermorelin in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Sermorelin FDA approved?

    Sermorelin was FDA-approved as Geref, in 1990 and 1997, and is no longer sold: its maker discontinued both products in 2008, and FDA determined in 2013 that they were not withdrawn for reasons of safety or effectiveness.

  • Is Sermorelin a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Sermorelin banned in sport?

    WADA bans sermorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.

  • What does FDA say about compounding Sermorelin?

    Sermorelin is the active ingredient of an FDA-approved drug, Geref, discontinued by its maker in 2008; FDA determined in 2013 that Geref was not withdrawn for reasons of safety or effectiveness. FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name sermorelin.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo